Brand Engagement Network, Inc. (NASDAQ: BNAI) and Skye Inteligencia LATAM have announced the creation of Skye Salud, a new Mexican entity that will develop a sovereign augmented‑intelligence platform for the country’s healthcare system. The joint venture will leverage BNAI’s Engagement Language Model (ELM™) to deliver secure, Spanish‑language AI tools that aim to modernize care delivery for more than 130 million Mexicans, with a focus on chronic disease management and the integration of fragmented electronic health records.
Skye Salud will operate as a closed‑loop platform that integrates with existing hospital information systems, supports clinical workflows, and enhances documentation and patient access. The platform’s architecture is designed to keep all data within Mexican borders, addressing the country’s growing demand for data sovereignty and compliance with evolving privacy regulations. By embedding BNAI’s ELM™—a model built for regulated industries—Skye Salud intends to reduce hallucinations and privacy risks while providing clinicians with real‑time decision support in Spanish.
The partnership represents a strategic pivot for BNAI, which has recently expanded its footprint in Latin America with a $5 million AI licensing deal announced on November 10 2025. Skye Inteligencia LATAM brings local market expertise and a track record of deploying AI solutions in Mexican healthcare settings, positioning the joint venture to tailor its offerings to Mexican clinical standards. BNAI’s focus on data‑sovereign, compliance‑first AI solutions aligns with the regulatory environment in Mexico, where the Federal Commission for Protection against Sanitary Risk (COFEPRIS) and the Ministry of Health are tightening data protection rules for health technology providers.
Financially, BNAI is a small, high‑growth company with a market capitalization of approximately $11.9 million. The stock had fallen 26 % in the week preceding the announcement, reflecting investor concerns about the company’s limited operating history and modest revenue base. Despite the recent price decline, the new venture is expected to open a significant revenue stream in a market that serves 130 million people and faces chronic disease burdens—over 14 million adults live with diabetes—and fragmented electronic records.
The initial launch of Skye Salud is targeted for the first quarter of 2026, pending regulatory approvals and development milestones. Acting CEO Tyler Luck emphasized that “Mexico represents a significant market opportunity to support healthcare modernization through secure augmented intelligence. Skye Salud aligns with BNAI’s strategy in regulated industries and will be developed to support ongoing efforts to strengthen clinical infrastructure.” The joint venture’s success will depend on navigating Mexico’s regulatory approval process and demonstrating the platform’s ability to integrate seamlessly with existing hospital systems.
Overall, the Skye Salud partnership positions BNAI to capture a share of Mexico’s growing digital health investment, while reinforcing its commitment to building trusted, sovereign AI solutions worldwide. The venture’s focus on data sovereignty, compliance, and local market expertise could provide a competitive edge in a sector where privacy and interoperability remain critical challenges.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.